Elior: UBS still on hold but raises TP

(CercleFinance.com) - UBS maintains its Neutral raring on the Elior share, while nudging up its target price for it to E2.
55 (from E2.4).

The analyst says that he intends to adjust estimates after FY 2023.

"Post FY23, we adjust estimates. We slightly increase FY24 revenue and adj. EBITA but cut EPS due to higher than previously expected financial expense", UBS says.

For the record, Elior is now aiming to generate E44m in cost synergies p.a. by 2026. All said, including the unchanged target for commercial synergies, the group's new target is to achieve E56m in annual recurring synergies by 2026, i.e. almost double the initial target.


Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.